2002, Number 4
<< Back Next >>
Gac Med Mex 2002; 138 (4)
Alterations in Hepatitic Metabolism Induced by Prolonged-Action Nifedipine in Mexican Population.
Palma-Aguirre JA, Campos-Lara M, Chávez-Negrete A
Language: Spanish
References: 7
Page: 381-383
PDF size: 25.56 Kb.
Text Extraction
No abstract0
REFERENCES
Palma-Aguirre JA, Castañeda-Hernández G, Chávez-Negrete A, Ponce-Monter H. Nifedipina. Farmacocinética e indicaciones terapéuticas. Rev Med IMSS 1999;37:47-58.
American Hospital Formulary Service. Drug Information. American Society of Healthy-System Pharmacists, lnc. Maryland. 2001. p. 1637-1643.
Palma-Aguirre JA, Montoya-Cabrera MA, du Souich P, et al. Discrepancy between bioavailability and hypotensive effect of oral and sublingual nifedipine. Am J Ther 1995;2:3-9.
Castañeda-Hernández G, Hoyo-Vadillo C, Palma-Aguirre JA, Flores-Murrieta F. Pharmacokinetics of oral nifedipine in different populations. J Clin Pharmacol 1993;33:140-145.
Castañeda-Hernández G, Palma-Aguirre JA, Montoya-Cabrera MA, Flores Murrieta F. lnterethnic variability in nifedipine disposition: reduced systemic plasma clearance in Mexican subjects. Br J Clin Pharmacol 1996; 41:433-434.
Ahsan CH, Renwick AG, Waller DG, et al. The influences of dose and ethnic origins on the pharmacokinetics of nifedipine. Clin Pharmacol Ther 1993; 54:329-338.
Myers MG. Dihydropyridine calcium antagonists and the trough: peak ratio; focus on adverse effects. J Hypertens Suppl 1994;12(8):S73-S77.
Full text